ZFIN ID: ZDB-PERS-060309-7
Paquet, Dominik
Email: dominik.paquet@med.uni-muenchen.de
URL: http://haass.web.med.uni-muenchen.de/
Address: Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) - Standort München Adolf Butenandt-Institute Biochemistry Ludwig-Maximilians University Munich Schillerstrasse 44 Muenchen, 80336 Germany
Phone: 49 89 - 2180 75 - 490
Fax: 49 89 2180 415


Giustiniani, J., Chambraud, B., Sardin, E., Dounane, O., Guillemeau, K., Nakatani, H., Paquet, D., Kamah, A., Landrieu, I., Lippens, G., Baulieu, E.E., Tawk, M. (2014) Immunophilin FKBP52 induces Tau-P301L filamentous assembly in vitro and modulates its activity in a model of tauopathy. Proceedings of the National Academy of Sciences of the United States of America. 111:4584-9
Paquet, D., PluciDska, G., Misgeld, T. (2014) In vivo imaging of mitochondria in intact zebrafish larvae. Methods in enzymology. 547:151-64
Plucinska, G., Paquet, D., Hruscha, A., Godinho, L., Haass, C., Schmid, B., and Misgeld, T. (2012) In vivo imaging of disease-related mitochondrial dynamics in a vertebrate model system. The Journal of neuroscience : the official journal of the Society for Neuroscience. 32(46):16203-16212
van Bebber, F., Paquet, D., Hruscha, A., Schmid, B., and Haass, C. (2010) Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish. Neurobiology of disease. 39(3):265-271
Fett, M.E., Pilsl, A., Paquet, D., van Bebber, F., Haass, C., Tatzelt, J., Schmid, B., and Winklhofer, K.F. (2010) Parkin Is Protective against Proteotoxic Stress in a Transgenic Zebrafish Model. PLoS One. 5(7):e11783
Paquet, D., Schmid, B., and Haass, C. (2010) Transgenic Zebrafish as a Novel Animal Model to Study Tauopathies and Other Neurodegenerative Disorders in vivo. Neuro-degenerative Diseases. 7(1-3):99-102
Paquet, D., Bhat, R., Sydow, A., Mandelkow, E.M., Berg, S., Hellberg, S., Fälting, J., Distel, M., Köster, R.W., Schmid, B., and Haass, C. (2009) A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J. Clin. Invest.. 119(5):1382-1395